Clinical Trials
Roche partners with Moderna to include SARS-CoV-2 antibody test...
Roche announced a partnership with Moderna Inc. to utilise the Elecsys® Anti-SARS-CoV-2 S antibody test in Moderna’s mRNA-1273 vaccine research trials. This will facilitate the...
Clinical Trials
Kaneka Eurogentec will manufacture INOVIO’s DNA vaccine candidate against...
INOVIO has assembled a global coalition of collaborators, partners and funders to rapidly advance the development of INO-4800, a DNA vaccine against the novel coronavirus...
Clinical Trials
Algernon completes patient enrollment in phase 2b/3 study of...
Algernon Pharmaceuticals, a clinical stage pharmaceutical development company, announced that the final patient has been enrolled in its multinational phase 2b/3 human study of NP-120...
Clinical Trials
Bharat Biotech underplays adverse event in Covaxin Phase 1...
Bharat Biotech, during its phase 1 trials, experienced an adverse event in a volunteer that it did not promptly admit to the public. As per...
Clinical Trials
Astrazeneca Says AZD1222 vaccine met primary efficacy endpoint in...
Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective in preventing...
Clinical Trials
EUA Begins Rolling Review of Modernas mRNA Vaccine Candidate...
Moderna, Inc.,a biotechnology company pioneering messenger RNA therapeutics and vaccines to create a new generation of transformative medicines for patients, announced that the EMA human...
Clinical Trials
Mallinckrodt Initiates Retrospective Study of the Use of Inhaled...
Mallinckrodt plc, a global biopharmaceutical company, announced initiation of a retrospective chart review study, titled "Nitric Oxide Treatment In COVID-19 Evaluation (NOTICE)" to collect real-world...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.